Last update :
19/11/2024
References   References 2692  
Type : Journal

Research teams : Nutley - Roche Laboratories
Authors : Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.
Title : Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
Reference : J Am Pharm Assoc ; 47, 6; 747-755. 2007

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionOseltamivir Antiviral
Stability in solutions Glass Kapseln 450 mg
Tamiflu®
Cherry syrup >> 30 ml
23-27°C Protect from light
5 Day
Stability in solutions Glass Kapseln 450 mg
Tamiflu®
Orasweet SF ® >> 30 ml
28-32°C Protect from light
13 Day
Stability in solutions Glass Kapseln 450 mg
Tamiflu®
Cherry syrup >> 30 ml
3-7°C Protect from light
35 Day
Stability in solutions Glass Kapseln 450 mg
Tamiflu®
Orasweet SF ® >> 30 ml
3-7°C Protect from light
35 Day
Stability in solutions plastic bottle Kapseln 450 mg
Tamiflu®
Cherry syrup >> 30 ml
23-27°C Protect from light
5 Day
Stability in solutions plastic bottle Kapseln 450 mg
Tamiflu®
Orasweet SF ® >> 30 ml
28-32°C Protect from light
13 Day
Stability in solutions plastic bottle Kapseln 450 mg
Tamiflu®
Cherry syrup >> 30 ml
3-7°C Protect from light
35 Day
Stability in solutions plastic bottle Kapseln 450 mg
Tamiflu®
Orasweet SF ® >> 30 ml
3-7°C Protect from light
35 Day

  Mentions Légales